Literature DB >> 12185043

To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy?

Laura Liberman1, Jennifer B Kaplan, Elizabeth A Morris, Andrea F Abramson, Jennifer H Menell, D David Dershaw.   

Abstract

OBJECTIVE: This study was undertaken to determine whether complete percutaneous excision rather than sampling of the mammographic target conveys any significant advantage or disadvantage at stereotactic 11-gauge vacuum-assisted biopsy.
MATERIALS AND METHODS: A retrospective review was performed of 788 consecutive solitary lesions in which the mammographic target was excised (n = 466) or sampled (n = 322) at stereotactic 11-gauge vacuum-assisted biopsy. Medical records and histologic findings were reviewed to determine the frequency of sparing surgery, discordance, histologic underestimation, rebiopsy, complete histologic removal of cancer, and complications. Statistical comparisons were made using the Fisher's exact test.
RESULTS: Complete excision rather than sampling of the mammographic target was associated with a significantly lower frequency of discordance (1/466, 0.2% vs 8/322, 2.5%; p = 0.004) and a trend toward fewer ductal carcinoma in situ underestimates (4/59, 6.8% vs 12/60, 20.0%; p = 0.07). Complete histologic removal of cancer was significantly more likely if the mammographic target was excised rather than sampled (19/91, 20.9% vs 7/106, 6.6%; p = 0.006); however, among 91 cancers in which the mammographic target was excised, surgery revealed residual cancer in 72 (79.1%). Complete excision rather than sampling of the mammographic target yielded no significant differences in the frequency of sparing surgery, atypical ductal hyperplasia underestimates, rebiopsy, or complications.
CONCLUSION: Complete excision rather than sampling of the mammographic target was associated with lower frequencies of discordance and ductal carcinoma in situ underestimation but had no other advantage or disadvantage. Among cancers in which the mammographic target was excised, surgery revealed residual cancer in almost 80%.

Entities:  

Mesh:

Year:  2002        PMID: 12185043     DOI: 10.2214/ajr.179.3.1790679

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  17 in total

Review 1.  Stereotactic and ultrasound-guided breast biopsy.

Authors:  T H Helbich; W Matzek; M H Fuchsjäger
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

2.  Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

Authors:  Hans-Peter Sinn; Zeinab Elsawaf; Birgit Helmchen; Sebastian Aulmann
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

Review 3.  Accuracy of ultrasound-guided, large-core needle breast biopsy.

Authors:  G Schueller; C Schueller-Weidekamm; T H Helbich
Journal:  Eur Radiol       Date:  2008-04-15       Impact factor: 5.315

4.  Mammotome(®) and EnCor (®): comparison of two systems for stereotactic vacuum-assisted core biopsy in the characterisation of suspicious mammographic microcalcifications alone.

Authors:  Giovanna Mariscotti; Manuela Durando; Mattia Robella; Francesca Angelino; Elisa Regini; Pier Paolo Campanino; Marco Belletti; Silvia Osano; Laura Bergamasco; Paolo Fonio; Giovanni Gandini
Journal:  Radiol Med       Date:  2014-08-15       Impact factor: 3.469

5.  Borderline breast lesions: comparison of malignancy underestimation rates with 14-gauge core needle biopsy versus 11-gauge vacuum-assisted device.

Authors:  Viviana Londero; Chiara Zuiani; Anna Linda; Luisa Battigelli; Giovanni Brondani; Massimo Bazzocchi
Journal:  Eur Radiol       Date:  2011-01-12       Impact factor: 5.315

6.  Vacuum-assisted stereotactic breast biopsy in the diagnosis and management of suspicious microcalcifications.

Authors:  Gül Esen; Burçin Tutar; Cihan Uras; Zerrin Calay; Ümit İnce; Onur Tutar
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

7.  Does ultrasound-guided directional vacuum-assisted removal help eliminate abnormal nipple discharge in patients with benign intraductal single mass?

Authors:  Jung Min Chang; Nariya Cho; Woo Kyung Moon; Jeong Seon Park; Se-Yeong Chung; Mijung Jang
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

8.  Vacuum assisted breast biopsy (VAB) excision of subcentimeter microcalcifications as an alternative to open biopsy for atypical ductal hyperplasia.

Authors:  Simone Schiaffino; Elena Massone; Licia Gristina; Piero Fregatti; Giuseppe Rescinito; Alessandro Villa; Daniele Friedman; Massimo Calabrese
Journal:  Br J Radiol       Date:  2018-02-23       Impact factor: 3.039

9.  Predictive factors for invasive cancer in surgical specimens following an initial diagnosis of ductal carcinoma in situ after stereotactic vacuum-assisted breast biopsy in microcalcification-only lesions.

Authors:  Hatice Gümüş; Philippa Mills; David Fish; Metehan Gümüş; Karina Cox; Haresh Devalia; Sue Jones; Peter Jones; Ali R Sever
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

10.  Effectiveness of the diagnostic pathway of BLES: could it be safely used as a therapeutic method in selected benign lesions?

Authors:  Tuğba İlkem Kurtoğlu Özçağlayan; Sibel Özkan Gürdal; Meltem Öznur; Ömer Özçağlayan; Mücahit Doğru; Birol Topçu
Journal:  Diagn Interv Radiol       Date:  2019-11       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.